Hans J.


Hans J. Stricker

Hans J. Stricker, M.D., is Vice Chair of the Vattikuti Urology Institute and Chair of Surgery for Henry Ford West Bloomfield Hospital.

Dr. Stricker has a special interest in robotic prostatectomy and has lectured and published extensively on the topic. He served as program chair of the International Robotic Urology Symposium (IRUS) in 2006, and has served on the IRUS faculty since 2002.

He also is active in Henry Ford Radiation Oncology’s gene therapy research for prostate cancer.

While studying for his bachelor’s of arts degree in Chemistry at Capital University in Columbus, Ohio, he was recognized as the American Chemical Society’s “Young Chemist of the Year.” He graduated summa cum laude from Capital, and then earned his medical degree from the University of Michigan Medical School in Ann Arbor. He also completed his training in General Surgery and Urology at the University of Michigan.

Dr. Stricker is a fellow of the American College of Surgeons. He is a member of the American Urology Association and its North Central Section; the Michigan Urologic Society; the Southwest Oncology Group; the American Medical Association; and the Reed M. Nesbit Urologic Society of the University of Michigan Department of Urology.



Bladder Cancer
Cancer Surgery
Genitourinary Cancer
Kidney Cancer
Prostate Cancer
Robotic Surgery
Surgery - Robotic
Urinary Tract
Vattikuti Urology Institute


Board Certifications:
American Board of Urology

Medical School Education:
University of Michigan Medical School - Graduation Date: 06/01/1988

Post Graduate Education:
University of Michigan Hospitals (MI) - General Surgery
University of Michigan Hospitals (MI) - Urology

  1. Young Alumni Award, Capital University, 2000
  2. Pfizer Academic Excellence in Urology, 1998
  3. Joseph C. Cerny Resident Teaching Award, 1998
  4. Michigan Urologic Society, Residents Day Competition- Second Place, 1993: Current Prostate Cancer Detection: How Low Can We Go?
  5. Michigan Urologic Society, Residents Day Competition- Second Place, 1991: Predicting Prostate Cancer Volumes: Mathematical and Laboratory Models and Their Clinical Implications



    • University of Michigan Medical School Honors:
    • Urology, 1987
    • Radiology, 1987
    • Pharmacology 625, 1986
    • Capital University Honors:
    • Summa Cum Laude, 1984
    • Erik John Earl Memorial Award, 1984
    • ACS Senior Chemist of the Year, 1984
    • Kappa Alpha Pi Academic Honors Society, 1983-84
    • Scholarship for Academic Honors, 1980-84


  1. American College of Surgeons 1996-present
  2. North Central Section of AUA 1995-present
  3. Michigan Urologic Society 1995-present
  4. Southwest Oncology Group 1995-present
  5. Nesbit Society 1993-present
  6. American Urologic Association 1990-present
  7. American Medical Association 1984-present


  1. Fellow, American College of Surgeons October 1996
  2. Diplomate, American Board of Urology, Certificate No. 11110 February 1995 Recertified Nov. 2003
  3. Diplomate, National Board of Medical Examiners May 1988
  4. State Licensure, Michigan No. 053400 1988-present
  5. Robotic Prostatectomy Certification January 2004
  6. KTP Greenlight PVP Laser Prostatectomy Certification July 2003
  7. Targis Microwave Thermotherapy Certification January 2000
  8. Holmium: Yag Laser Certification December 1997
  9. Ultrasonically Guided I125/ Pdl03 Prostate Seed May 1996
  10. Implant Certification Radical Perineal Prostatectomy Preceptorship February 1996
  11. Nd: Yag Laser Certification November 1993
  12. Contigen Implant Certification November 1993
  13. Foundations of Microsurgical Skills Certification October 199
  1. Krane, L Spencer. Kaul, Sanjeev A. Stricker HJ. Peabody, James O. Menon, Mani. Agarwal, Piyush K. Men Presenting for radical prostatectomy on preoperative statin therapy have reduced serum prostate specific antigen. J. Urol. 2010 Jan; 183(1):118-24.
  2. Krane, L Spencer. Wambi, Christel. Bhandari, Akshay. Stricker HJ. Posterior support for urethrovesical anastomosis in robotic radical prostatectomy: Single surgeon analysis. Can J Urol. 2009 Oct; 16(5):4836-40.
  3. Bhandari A. Boris RS. Laungani RG. Stricker HJ. Ureteral inguinal hernia in a pelvic kidney. J. Urol. 2009 Jan; 181(1):333.
  4. Amin MB. Paner GP. Alvardo-Cabrero I. Young AN. Stricker HJ. Lyles RH. Moch H. Chromophobe renal cell carcinoma: histomorphologic characteristics and evaluation of conventional pathologic prognostic parameters in 145 cases. Amer. J. Surg. Path. 2008 Dec; 32(12):1822-34.
  5. Barton KN. Stricker HJ. Brown SL. Elshaikh M. Aref I. Lu M. Pegg J. Zhang Y. Karvelis KC. Siddiqui F. Kim JH. Freytag SO. Movsas B. Phase I Study of noninvasive imaging of adenovirus-mediated gene expression in the human prostate. Mol. Ther. 2008 Oct; 16(10):1761-9.
  6. Yuh B. Laungani R. Perlmutter A. Eun D. Peabody JO. Mohler JL. Stricker HJ. Guru KA. Robot-Assisted Millin’s retropubic prostatectomy: case series. Can J Urol. 2008 Jun; 15(3):4101-5.
  7. Boris RS, Kaul SA, Sarle RC, Stricker HJ. Radical prostatectomy: a single surgeon comparison of retropubic, perineal, and robotic approaches. Can J Urol. 2007 Jun;14(3):3566-70.
  8. Siddiqui F, Barton KN, Stricker HJ, Steyn PF, Larue SM, Karvelis KC, Sparks RB, Kim JH, Brown SL, Freytag SO. Design considerations for incorporating sodium iodide symporter reporter gene imaging into prostate cancer gene therapy trials. Hum Gene Ther. 2007 Apr;18(4):312-22. Freytag SO, Stricker H, Movsas B, Kim JH. Prostate cancer gene therapy clinical trials. Mol Ther. 2007 Jun;15(6):1042-52.
  9. Epub 2007 Apr 3. Freytag SO, Movsas B, Aref I, Stricker H, Peabody J, Pegg J, Zhang Y, Barton KN, Brown SL, Lu M, Savera A, Kim JH. Phase I trial of replication-competent adenovirus-mediated suicide gene therapy combined with IMRT for prostate cancer. Mol Ther. 2007 May;15(5):1016-23.
  10. Epub 2007 Mar 20. Freytag SO, Stricker H, Peabody J, Pegg J, Paielli D, Movsas B, Barton KN, Brown SL, Lu M, Kim JH. Five-year follow-up of trial of replication-competent adenovirus-mediated suicide gene therapy for treatment of prostate cancer. Mol Ther. 2007 Mar;15(3):636-42.
  11. Epub 2007 Jan 16. Kaul S, Laungani R, Sarle R, Stricker H, Peabody J, Littleton R, Menon M. da Vinci-assisted robotic partial nephrectomy: technique and results at a mean of 15 months of follow-up. Eur Urol. 2007 Jan;51(1):186-91; discussion 191-2.
  12. Epub 2006 Jun 21. Barton KN, Stricker H, Kolozsvary A, Kohl R, Heisey G, Nagaraja TN, Zhu G, Lu M, Kim JH, Freytag SO, Brown SL. Polyethylene glycol (molecular weight 400 DA) vehicle improves gene expression of adenovirus mediated gene therapy. J Urol. 2006 May;175(5):1921-5.


  1. cont Salama ME, Guru K, Stricker H, Peterson E, Peabody J, Menon M, Amin MB, De Peralta-Venturina M. pT1 substaging in renal cell carcinoma: validation of the 2002 TNM staging modification of malignant renal epithelial tumors. J Urol. 2005 May;173(5):1492-5.
  2. Barton KN, Xia X, Yan H, Stricker H, Heisey G, Yin FF, Nagaraja TN, Zhu G, Kolozsvary A, Fenstermacher JD, Lu M, Kim JH, Freytag SO, Brown SL. A quantitative method for measuring gene expression magnitude and volume delivered by gene therapy vectors. Mol Ther. 2004 Apr;9(4):625-31.
  3. Freytag SO, Stricker H, Pegg J, Paielli D, Pradhan DG, Peabody J, DePeralta-Venturina M, Xia X, Brown S, Lu M, Kim JH. Phase I study of replication-competent adenovirus-mediated double-suicide gene therapy in combination with conventional-dose three-dimensional conformal radiation therapy for the treatment of newly diagnosed, intermediate- to high-risk prostate cancer. Cancer Res. 2003 Nov 1;63(21):7497-506.
  4. Barton KN, Tyson D, Stricker H, Lew YS, Heisey G, Koul S, de la Zerda A, Yin FF, Yan H, Nagaraja TN, Randall KA, Jin GK, Fenstermacher JD, Jhiang S, Ho Kim J, Freytag SO, Brown SL. GENIS: gene expression of sodium iodide symporter for noninvasive imaging of gene therapy vectors and quantification of gene expression in vivo. Mol Ther. 2003 Sep;8(3):508-18.
  5. Freytag SO, Khil M, Stricker H, Peabody J, Menon M, DePeralta-Venturina M, Nafziger D, Pegg J, Paielli D, Brown S, Barton K, Lu M, Aguilar-Cordova E, Kim JH. Phase I study of replication-competent adenovirus-mediated double suicide gene therapy for the treatment of locally recurrent prostate cancer. Cancer Res. 2002 Sep 1;62(17):4968-76.
  6. Amin MB, Amin MB, Tamboli P, Javidan J, Stricker H, de-Peralta Venturina M, Deshpande A, Menon M. Prognostic impact of histologic subtyping of adult renal epithelial neoplasms: an experience of 405 cases. Am J Surg Pathol. 2002 Mar;26(3):281-91.
  7. Tewari A, Krueger A, Peabody J, Stricker HJ, Menon M. Prostate cancer: recent advances, Part I– detection and staging. Hospital Physician 2002. Tewari A, Krueger A, McIntire L, Guru K, Peabody J, Stricker HJ, Menon M. Prostate cancer: recent advances, Part II– Management. Hospital Physician 2002.
  8. Tewari A, Issa M, El-Galley R, Stricker H, Peabody J, Pow-Sang J, Shukla A, Wajsman Z, Rubin M, Wei J, Montie J, Demers R, Johnson CC, Lamerato L, Divine GW, Crawford ED, Gamito EJ, Farah R, Narayan P, Carlson G, Menon M. Genetic adaptive neural network to predict biochemical failure after radical prostatectomy: a multi-institutional study. Mol Urol. 2001 Winter;5(4):163-9.
  9. Stricker, HJ. Luteinizing hormone-releasing hormone antagonists in prostate cancer. Urology. 2001 Aug;58(2 Suppl 1):24-7.
  10. cont Carroll PR, Fair WR, Grossfeld GD, Heston WD, Lieberman R, Malkowicz SB, Stricker HJ, Sylvester J, Peehl DM, Meyer F, Hart C. Overview consensus statement. Urology. 2001 Aug;58(2 Suppl 1):1-4.
  11. de Peralta-Venturina M, Moch H, Amin M, Tamboli P, Hailemariam S, Mihatsch M, Javidan J, Stricker H, Ro JY, Amin MB. Sarcomatoid differentiation in renal cell carcinoma: a study of 101 cases. Am J Surg Pathol. 2001 Mar;25(3):275-84.
  12. Rivers KK, Rivers EP, Stricker HJ, Lewis J, Urrunaga J, Karriem V. The clinical utility of serologic markers in the evaluation of the acute scrotum. Acad Emerg Med 2000 Sep;7(9):1069-72.
  13. Tewari A, Konety B, Bahandri, A, Stricker HJ, Peabody J, Menon M. Recent advances in prostate cancer staging. Medscape October 1999. Javidan J, Stricker HJ, Tamboli P, Amin MB, Peabody JO, Deshpande A, Menon M, Amin MB. Prognostic significance of the 1997 TNM classification of renal cell carcinoma. J Urol. 1999 Oct;162(4):1277-81.
  14. Bonzani RA, Stricker HJ, Peabody JO, Menon M. Cost comparison of orchiectomy and leuprolide in metastatic prostate cancer. J Urol. 1998 Dec;160(6 Pt 2):2446-9. Stricker HJ, Jay JK, Linden MD, Tamboli P, Amin MB. Determining prognosis of clinically localized prostate cancer by immunohistochemical detection of mutant p53. Urology. 1996 Mar;47(3):366-9.
  15. Stricker HJ, Kunin JR, Faerber GJ. Congenital prostatic cyst causing ejaculatory duct obstruction: management by transrectal cyst aspiration. J Urol. 1993 May;149(5):1141-3.
  16. Stricker HJ, Ruddock LJ, Wan J, Belville WD. Detection of non-palpable prostate cancer. A mathematical and laboratory model. Br J Urol. 1993 Jan;71(1):43-6.